Antiepileptic Drugs-Induced Enuresis in Children: An Overview

Arya Sathyan1, Reshma Scaria1, Pavithra Arunachalam1

  • 1KMCH College of Pharmacy, Coimbatore, Tamil Nadu, India.

Insights

Antiepileptic drugs can cause enuresis (bedwetting) in children, an underreported side effect. Recognizing this adverse drug reaction is crucial for managing epilepsy treatment and reducing patient distress.

Area of Science:

  • Pediatric Neurology
  • Pharmacology
  • Adverse Drug Reactions

Background:

  • Enuresis, or bedwetting, is a common childhood condition that can also be an adverse drug reaction.
  • Antiepileptic drugs (AEDs) are frequently prescribed for long-term management of epilepsy in children.
  • Drug-induced enuresis can cause significant embarrassment and psychological distress for affected children and their families.

Purpose of the Study:

  • To review and evaluate antiepileptic drugs known to induce enuresis in pediatric populations.
  • To highlight enuresis as an underreported adverse effect of AEDs in children.
  • To synthesize current knowledge on AED-induced enuresis for improved clinical awareness.

Main Methods:

  • A comprehensive PubMed literature search was conducted from 1917 to July 2020.
  • Keywords included "antiepileptic drugs," "enuresis," "pediatric population," "drug-induced enuresis," and "epilepsy."
  • Studies published in English focusing on AED-induced enuresis in children were selected for review.

Main Results:

  • Enuresis is an underreported adverse drug reaction associated with certain antiepileptic drugs in children.
  • The occurrence of enuresis can complicate long-term epilepsy management and impact a child's quality of life.
  • While often outgrown, drug-induced enuresis can cause significant distress and requires careful consideration during treatment.

Conclusions:

  • Identifying enuresis as a potential adverse effect of AEDs is vital for minimizing stress in pediatric patients.
  • Further research is needed to elucidate the exact mechanisms of AED-induced enuresis.
  • Understanding and addressing this side effect can contribute to safer and more effective epilepsy treatment in children.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
358
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
348
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
590
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.1K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
745
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
516